. SHIELD forms weak, physical gels upon mixing of C7 with PEG-P and/or PEG-P-PNIPAM. a) Photographs of SHIELD gels forming upon mixing of C7 and PEG-P and PEG-P-PNIPAM. Photo credit: Laura Marquardt, Stanford University. b) NMR spectra of PEG-P and PEG-P-PNIPAM reactions with 81 and ~70% efficiencies, respectively. Solvent DMSO. c,d) Additional individual NMR spectra of c) PEG-P and d) PEG-P-PNIPAM synthesis reactions. Solvent dH2O with reaction efficiencies of ~ 8 P per PEG and ~6 P and 1 PNIPAM per PEG respectively. Figure S2 . Recombinant engineering of C7 variants with different cell-adhesive domains. a) Schematic of C7 expression protocol including 1) insertion of C7 sequence into pET-15b expression plasmid, 2) transformation and cloning of C& variants in competent DH5a E. coli, 3) transformation of plasmids into BL21(DE3) pLysS expression E. coli and protein expression by IPTG induction, 4) Ni+ column purification of expressed proteins with 6x-His-tag, and 5) protein quantification of expressed proteins. b) Full amino acid sequences of C7 variants RDG, YIGSR, and IKVAV. Figure S3 . C7 variants express at similar molecular weights. C7 variants (RGD, RDG, YIGSR, and IKVAV) all express at similar apparent molecular weights of ~120 kDa. C7 has a molecular weight of approximately 60 kDa but runs at a higher apparent molecular weight due to acidic and hydrophilic spacer domains. Supplementary Figure S9 . Culture of primary SCs in 2D and 3D. a) Two-dimensional expansion culture of primary Fischer SCs on poly-L-Lysine coated tissue culture plastic at 4, 10, and 20x magnification. b) SCs immediately after encapsulation in SHIELD RGD and RDG gels at day 0 are homogenously distributed throughout the gels as single cells. Images are at 20x magnification. SCs maintain normal phenotypic expression of SC markers P75 and S100 after 5 days in 3D SHIELD culture. Red, P75, Green, S100, Blue, DAPI. c) SCs demonstrate high viability 3 days after encapsulation within soft, medium, and stiff SHIELD RGD gels. Green, Calcein AM, live cells, Red, ethidium homodimer-1, dead cells. Supplementary Figure S14 . Spinal cord section analysis of injured and uninjured hemispheres reveals no difference in endogenous marker expression. Mean intensity of Tomato Lectin (vasculature, microglia), Iba1 (microglia), and ED1 (macrophages) across the both (total) hemispheres, right (injured) hemisphere, left (uninjured) hemisphere were not significantly different between groups. Furthermore, normalized right to left (injured to uninjured) mean intensity was similar between all groups. Data are mean ± SEM. n=7-8.
Supplementary

SM Table S1
Supplementary Table S1. SHIELD formulations with varying PNIPAM concentrations. Soft, medium, and stiff SHIELD gel formulations are fabricated with increasing (0, 1.25, and 2.5) wt% PNIPAM.
SM Table S2
Supplementary Table S2 . Experimental groups and animal numbers for in vivo SC transplantation study. The total number of animals per group per timepoint, the percentage of animals with P75+ SCs observed within spinal cord slices, and the number of animals analyzed for behavioral recovery are reported.
